Regulatory clarity urged for CME’s single-stock futures
Skip to main content
SEC short selling and market access rules may hamper clearing and broker participation
The regulatory treatment of CME’s single-stock futures (SSFs) may require clarification for the contracts to gain wider traction, as a dual-oversight framework introduces securities-based market access and short-selling rules that do not easily fit the futures construct.
CME launched more than 70 SSFs in July, on names including Apple, Nvidia and SpaceX, reviving the product after a six-year hiatus
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
Most read articles loading…
Back to Top
You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.
